Objective The diagnostic criteria for primary biliary cirrhosis (PBC) 
Introduction

Primary biliary cirrhosis (PBC) is a chronic, progressive cholestatic liver disease of unknown cause that usually affects middle-aged women. The condition is characterized by the destruction of small intrahepatic bile ducts, portal inflammation and progressive scarring (1, 2). Patients with PBC are clinically classified as being asymptomatic (a-PBC) without any apparent clinical manifestations and symptomatic (s-PBC). These classifications are useful in predicting the prognosis in most patients with PBC. However, there are some discrepancies among previous studies regarding the natural history of a-PBC and s-PBC. One of the possible reasons is that standardized definitions of a-PBC and s-PBC have yet to be established internationally.
The diagnostic criteria for PBC were established in Japan by the Intractable Liver Disease Research Project Team of the Ministry of Health and Welfare in 1992 (3). According to these criteria, s-PBC was defined as a stage accompanied by symptoms referable to liver impairment and s-PBC was further divided into s1-PBC showing skin pruritus and s2-
I n c i d e n c e o f p a t i e n t s wi t h a -P B C, n s -P B C a n d c s -P B C a t ( a ) t h e t i me o f d i a g n o s i s a n d ( b ) t h e f i n a l e v a l u a t i o n ( n = 2 0 8 ) .
(A) 
(B)
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Clinical profiles of ns-PBC
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. The initial symptoms of ns-PBC were esophageal varices (n=17) and ascites (n=3). No patients were initially complicated with hepatic encephalopathy. The laboratory data at diagnosis was compared among the three groups (Table 2). The platelet count and prothrombin time of patients with ns-PBC was significantly lower, whereas the level of serum bilirubin was significantly higher than those of a-PBC. Serum levels of bilirubin, ALT and ALP of patients with ns-PBC were significantly lower than those with cs-PBC. The prevalence of antinuclear antibody, AMA, and anti-centromere antibody was not different among the three groups. The prognosis of ns-PBC was poorer than a-PBC (p< 0.001), but similar to cs-PBC (
Progression to ns-PBC from a-PBC
The clinical course of a-PBC was analyzed (Fig. 3) F i g u r e 3 . T h e p r o g r e s s i o n o f s y mp t o ms i n p a t i e n t s wi t h a -P B C a t t h e t i me o f d i a g n o s i s ( n = 1 6 6 ) .
a to a-PBC 86.1% a to ns-PBC 7.8% a to cs-PBC 6.0% 1 3 ) , a n d a -t o -c s ( n = 1 0 ) . * p < 0 . 0 5 , * * p < 0 . 0 1 . (Fig. 4) . (Table 2 ). In addition, these patients had a poorer prognosis than a-PBC (Fig. 2a) (Fig. 3) . Signs of liver-related symptoms of "conventional" PBC, such as skin pruritus and jaundice and those of portal hypertension shared a similar frequency as initial symptoms (Fig. 3) (11, 12) . Nakamura et al (11) T a b l e 3 . L a b o r a t o r y Da t a a n d Hi s t o l o g i c a l S t a g e o f t h e P a t i e n t 
F i g u r e 4 . Ka p l a n -Me i e r s u r v i v a l c u r v e s a c c o r d i n g t o t h e s y mp t o ms i n P B C p a t i e n t s f r o m t h e t i me o f d i a g n o s i s t o t h e s t u d y e n d p o i n t . a -t o -a ( n = 1 4 3 ) , a -t o -n s ( n =
months). The initial symptoms of the patients who progressed to ns-PBC were esophageal varices (n=11) and ascites (n=2). On the other hand, those who progressed to cs-PBC were pruritus (n=9) and jaundice (n=1). The rate of progression to ns-PBC (0.84%/year) was lower than that to cs-PBC (1.10%/year). There was no difference in the gender and age at diagnosis among the groups (data not shown). The prognosis was significantly poorer in patients who progressed to ns-PBC (a-to-ns) than those who remained a-PBC (a-to-a; p<0.001), but similar to those who progress to cs-PBC according to a Kaplan-Meier analysis
The data at diagnosis as a-PBC was compared between the a-to-ns group and a-to-a group (
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